Tocqueville Asset Management L.P. Pacira Bio Sciences, Inc. Transaction History

Tocqueville Asset Management L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$54.64 - $61.3 $273,200 - $306,500	-5,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$59.18 - $69.99 $591 - $699	-10 Reduced 0.2%	5,000 $303,000
Q4 2020 Feb 16, 2021	SELL	$50.47 - $66.26 $353 - $463	-7 Reduced 0.14%	5,010 $300,000
Q3 2020 Nov 16, 2020	BUY	$51.97 - $63.0 $883 - $1,071	17 Added 0.34%	5,017 $302,000
Q2 2020 Aug 12, 2020	BUY	$30.8 - $52.47 $154,000 - $262,350	5,000 New	5,000 $262,000
Q3 2019 Oct 31, 2019	SELL	$35.66 - $44.99 $174,733 - $220,451	-4,900 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$36.57 - $47.97 $73,140 - $95,940	-2,000 Reduced 28.99%	4,900 $213,000
Q1 2019 Apr 30, 2019	SELL	$36.47 - $42.17 $40,117 - $46,387	-1,100 Reduced 13.75%	6,900 $263,000
Q4 2018 Feb 08, 2019	SELL	$41.31 - $52.16 $82,620 - $104,320	-2,000 Reduced 20.0%	8,000 $344,000
Q3 2018 Nov 13, 2018	BUY	$32.85 - $52.0 $328,500 - $520,000	10,000 New	10,000 $492,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.